10 Best Biotech Stocks Under $10 to Buy
Biotechnology stocks have delivered strong gains in 2026, supported by encouraging clinical trial results, regulatory approvals, and growth in drug sales.
Ocular Therapeutix Inc (OCUL)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 19,686,282 | $193,319,289 | 2.81% | |
| 2. | VenBio Select Advisor Kurt Von Emster | 12,540,000 | $123,142,800 | +2% | 1.11% |
| 3. | Logos Capital Arsani William | 5,300,000 | $52,046,000 | +38% | 2.24% |
| 4. | Point72 Asset Management Steve Cohen | 3,292,193 | $32,329,335 | -41% | 0.04% |
| 5. | Balyasny Asset Management Dmitry Balyasny | 2,270,707 | $22,298,343 | -16% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.66 | 60,229 | $461,354.14 | 246,933 | 2026-02-20 | Filing | |
| $6.96 | 10,000 | $69,600.00 | 172,704 | 2025-05-08 | Filing | |
| $7.52 | 930,851 | $6,999,999.52 | 8,591,401 | 2024-02-26 | Filing | |
| $3.25 | 1,538,461 | $4,999,998.25 | 7,660,550 | 2023-12-14 | Filing | |
| $3.81 | 6,500 | $24,765.00 | 6,500 | 2023-08-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.29 | 11,984 | $87,363.36 | 140,484 | 2026-10-08 | Filing | |
| $7.05 | 9,990 | $70,429.50 | 254,388 | 2026-10-02 | Filing | |
| $7.05 | 10,869 | $76,626.45 | 307,457 | 2026-10-02 | Filing | |
| $10.24 | 1,099 | $11,253.76 | 366,529 | 2026-08-31 | Filing | |
| $10.77 | 3,035 | $32,686.95 | 264,378 | 2026-08-24 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,623,597 | $20,122,989 | 3.14% | |
| 2. | 467,325 | $3,584,383 | 0.53% | |
| 3. | 370,000 | $2,837,900 | 0.06% | |
| 4. | 138,128 | $1,059,442 | 0.03% | |
| 5. | 121,000 | $928,070 | 0% |
News See All
Is Ocular Therapeutix (OCUL) Stock a Buy Ahead of Its Major NDA Catalyst?
In the high-stakes realm of clinical-stage biotechnology, long-term shareholder value is fundamentally forged by pipeline assets that solve deep-seated clinical bottlenecks while offering significant ...
3 Best Stocks With 150%+ Upside to Buy This Week, According to Analysts
Wall Street analysts see significant upside potential in several stocks this week, with three companies offering more than 150% upside based on the...
Ocular Therapeutix (OCUL): Faster Path To Approval Comes With Rising Costs
On August 3, Ocular Therapeutix (NASDAQ:OCUL) reported second-quarter 2026 financial results that read as much like a regulatory update as an earnings report.
3 Best Stocks With 140%+ Upside to Buy in September, According to Analysts
September is usually the weakest month for stocks, and this year too, the month has started under pressure from rising yields and geopolitical tens...
Is Ocular Therapeuticx, Inc. (OCUL) Stock Positioned for Growth After Positive FDA Feedback on Axpaxli?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Ocular Therapeuticx, Inc. (NASDAQ:OCUL) is among the best healthcare stocks.
10 Best Healthcare Stocks to Buy According to Wall Street Analysts
In this article, we will be taking a look at the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. The U.S.
10 Best Biotech Stocks with Highest Upside Potential
In this article, we will take a look at some of the best biotech stocks that are currently offering attractive upside to investors. On April 16, reports from J.P.
Ocular Therapeutix (OCUL) Announces Additional Positive Data From the SOL-1 Phase 3 Superiority Trial of AXPAXLI
Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the best low priced biotech stocks to invest in. Ocular Therapeutix Inc.
8 Best Low Priced Biotech Stocks to Invest In
In this article, we will look at the 8 Best Low Priced Biotech Stocks to Invest In.
Hedge Fund Resource Center